Eighteen years of experience in Mohs micrographic surgery and conventional excision for nonmelanoma skin cancer treated by a single facial plastic surgeon and pathologist

Laryngoscope

Volumn 120, Issue 12, 2010, Pages 2378-2384

  Van Der Eerden, Paul A ^a   Prins, M Eric F ^b   Lohuis, Peter J F M ^c   Balm, Fons A J M ^c   Vuyk, Hade D ^b  

^a T Lange Land Ziekenhuis   (Netherlands)

^b Tergooi Hospitals   (Netherlands)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

conventional excision; facial reconstructive surgery; Mohs micrographic surgery; Nonmelanoma skin cancer; recurrence rates

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CHEMOSURGERY; CONTROLLED STUDY; EXCISION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PATHOLOGIST; PLASTIC SURGERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN CANCER;

AGED; DISEASE-FREE SURVIVAL; FACE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY, CLINICAL; PHYSICIANS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURGERY, PLASTIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 78649677614     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21139     Document Type: Article

References (24)

1. de Vries E, van de Poll-Franse LV, Louwman WJ, de Gruijl FR, Coebergh JW., Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol 2005; 152: 481-488.
2. Randle HW., Basal cell carcinoma. Identification and treatment of the high-risk patient. Dermatol Surg 1996; 22: 255-261.
3. Batra RS, Kelley LC., Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol 2002; 138: 1043-1051.
4. Rowe DE, Carroll RJ, Day CL Jr., Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992; 26: 976-990.
5. Motley R, Kersey P, Lawrence C., Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Plast Surg 2003; 56: 85-91.
6. Bath-Hextall FJ, Perkins W, Bong J, Williams HC,. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2007:CD003412.
7. Thissen MR, Neumann MH, Schouten LJ., A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999; 135: 1177-1183.
8. Rowe DE, Carroll RJ, Day CL Jr., Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15: 315-328.
9. Rowe DE, Carroll RJ, Day CL Jr,. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989; 15: 424-431.
10. Kuijpers DI, Thissen MR, Neumann MH., Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy. Am J Clin Dermatol 2002; 3: 247-259.
11. Silverman MK, Kopf AW, Bart RS, Grin CM, Levenstein MS., Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision. J Dermatol Surg Oncol 1992; 18: 471-476.
12. Smeets N,. Cosmetic results of treatment of facial basal cell carcinoma; a comparison between Mohs micrographic surgery and surgical excision. Thesis on refining indications for Mohs micrographic surgery in treatment of facial basal cell carcinoma. 2004: 75-87.
13. Drake LA, Ceilley RI, Cornelison RL, et al. Guidelines of care for basal cell carcinoma. The American Academy of Dermatology Committee on Guidelines of Care. J Am Acad Dermatol 1992; 26: 117-120.
14. Avril MF, Auperin A, Margulis A, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997; 76: 100-106.
15. Walker P, Hill D,. Surgical treatment of basal cell carcinomas using standard postoperative histological assessment. Australas J Dermatol 2006; 47: 1-12.
16. Malhotra R, Huilgol SC, Huynh NT, Selva D., The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology 2004; 111: 631-636. (Pubitemid 38429659)
17. Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R., Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol 2005; 53: 253-260. (Pubitemid 40979582)
18. Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R., Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol 2005; 53: 452-457. (Pubitemid 41195967)
19. Mosterd K, Krekels GA, Nieman FH, et al. Surgical excision versus Mohs micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 2008; 9: 1149-1156.
20. Griffiths RW, Suvarna SK, Stone J., Do basal cell carcinomas recur after complete conventional surgical excision? Br J Plast Surg 2005; 58: 795-805.
21. Rhodes LE, de Rie MA, Leifsdottir R, et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 2007; 143: 1131-1136.
22. Otley CC., Mohs micrographic surgery for basal-cell carcinoma of the face. Lancet 2005; 365: 1226-1227; author reply 1227.
23. Wagner RF Jr, Cottel WI., Multifocal recurrent basal cell carcinoma following primary tumor treatment by electrodesiccation and curettage. J Am Acad Dermatol 1987; 17: 1047-1049.
24. Vuyk H, Lohuis P., Cutaneous malignancies of the head and neck. In Facial plastic and reconstructive surgery. New York, NY: Hodder Arnold Publications; 2006: 383-408.